MedPath

A study comparing efficacy of two drops in patients undergoing a laser for closed angles

Phase 4
Conditions
Health Condition 1: H400- Glaucoma suspect
Registration Number
CTRI/2018/10/016227
Lead Sponsor
Aravind Eye Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Primary angle closure suspects

2)Primary angle closure not started in anti-glaucoma medications post laser peripheral iridotomy

3)Best corrected visual acuity of 6/12 or better

Exclusion Criteria

1)Corneal pathology like dry eyes

2)Significant cataract which is obscuring undilated disc evaluation

3)PAC patients who are started on glaucoma medication before or immediately after LPI

4)PACG and Secondary angle closure glaucoma

5)History of any topical therapy including NSAIDâ??s within the past 30 days prior to LPI

6)Patient on systemic steroids or non-steroidal anti-inflammatory drugs

7) Any History of Laser or intraocular surgery

8)Pregnant or nursing mothers

9)Monocular patients

10)Any evidence of uveitis (old or new)

11) Patients with bleeding in the eye after the LPI

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath